global drug pipeline
Chinese Biotechs Shed Fast-Follower Reputations as Innovation Surges in 2025
Chinese biotech innovation; fast-follower to leader; biopharma R&D; global drug pipeline; regulatory reforms; clinical trials; Made in China 2025; novel drug candidates